Market Research Logo

Global Nucleic Acid Testing Market 2016-2020

Global Nucleic Acid Testing Market 2016-2020

About Nucleic Acid Testing

Nucleic acid testing (NAT) is the process involved in the detection of viral DNAs and RNAs in blood samples of individuals. NAT or nucleic acid amplification test (NAAT) is one of the fastest growing segments in the in-vitro diagnostics market (IVD). There are different types of NAT techniques such as Polymerase chain reaction (PCR), Strand displacement amplification (SDA), Ligase chain reaction (LCR), Transcription-mediated amplification (TMA), Nucleic acid sequence based amplification (NASBA) and whole genome sequencing.

Technavio’s analysts forecast the global nucleic acid testing market to grow at a CAGR of 9.96% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global nucleic acid testing market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top vendors operating in the market.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Nucleic Acid Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Laboratories
  • Roche Molecular Systems
  • Siemens Healthineers
  • Hologic
  • Qiagen
Other prominent vendors
  • Accriva Diagnostics
  • Acon Laboratories
  • Affymetrix
  • Ahram Biosystem
  • Asuragen
  • Biocartis
  • Bio-Rad Laboratories
  • Cepheid
  • DiagCor
  • EKF Diagnostics
  • Erba Diagnostics
  • Randox Laboratories
Market driver
  • Higher adoption rate of molecular point-of-care (POC) testing.
  • For a full, detailed list, view our report
Market challenge
  • Risks associated with molecular diagnosis.
  • For a full, detailed list, view our report
Market trend
  • Advances in precision and personalized medicine.
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Nucleic Acid Testing Market 2016-2020

Technavio recognizes the following companies as the key players in the global nucleic acid testing market: Abbott Laboratories, Roche Molecular Systems, Siemens Healthineers, Hologic, and Qiagen.

Other prominent vendors in the market are: Accriva Diagnostics, Acon Laboratories, Affymetrix, Ahram Biosystem, Asuragen, Biocartis, Bio-Rad Laboratories, Cepheid, DiagCor, EKF Diagnostics, Erba Diagnostics, and Randox Laboratories.

Commenting on the report, an analyst from Technavio’s team said: “One of latest trends in the market is next generation sequencing. Next generation sequencing (NGS) is the game changing trend in the IVD market due to its wide range of methods being readily available to the researchers. This sequencing method helps in answering any question about the genome, epitome and transcriptome of an organism. The process of sequencing has emerged as a technology boom for the clinical diagnosis field. It enables doctors and researchers in the detection of various infectious diseases such as Chlamydia trachomatis/Neisseria gonorrhoeae infection and pulmonary tuberculosis. Some of the most common NGS methods trending in the molecular diagnosis field are exome sequencing, total RNA and mRNA sequencing.”

According to the report, one of the primary drivers in the market is genome engineering and gene editing on rise. Genome engineering is one of the new technologies in the IVD market, which is gaining quick acceptance and serve beneficial in transforming healthcare system. Genome sequencing in molecular diagnostics helps in the detection of most complex diseases such as cancer and HIV. The next generation sequencing is one of the lucrative investments for pharmaceutical companies. The market is witnessing higher investment in the genomics research, government funding for gene therapy and other related techniques. There is a rise in the demand for gene editing for the alteration of genetic framework of an organism. This helps in facilitating the removal of defective gene and infusing corrective one resuming the genetic framework of body. With the use of technologies such as CRISPR and antisense technology, the researchers aim to change the prevailing healthcare scenario. Along with the improvement in blood screening process through NAT, the researchers aim to use the technology of gene editing for the treatment of incurable diseases such as HIV and cancer.

Further, the report states that one major challenge in the market is risks associated with molecular diagnosis. With the advent of new technologies in the market, the process of clinical diagnostics has undergone a transformation. The NAT blood screening process has served beneficial in determining infectious agents. However, the molecular diagnosis process involved in the screening of infectious diseases and genetic variation have some risks associated with it. The standardization of the system makes the process of optimization a tedious task. But, it plays a key role in maintaining the accuracy of results. The diagnostic systems lack the feature for determining sample type and volume. This acts a constraint in development of efficient NAT screening systems and integration of systems. There is a lack in the integration of diagnostic assays along with the next generation screening systems. The improved sensory system for biosensors is an unmet demand of the molecular diagnostics. The sensitivity for biosensors will ensure accuracy and eliminate enzymatic in-vitro amplification process. These risks divert the growth of the market.

Companies Mentioned

Abbott Laboratories, Roche Molecular Systems, Siemens Healthineers, Hologic, Qiagen, Accriva Diagnostics, Acon Laboratories, Affymetrix, Ahram Biosystem, Asuragen, Biocartis, Bio-Rad Laboratories, Cepheid, DiagCor, EKF Diagnostics, Erba Diagnostics, Randox Laboratories.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
  • Top-vendor offerings
    • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global nucleic acid testing market 2015-2020 ($ billions)
      • Table Global nucleic acid testing market diversification
      • Table Impact assessment for global nucleic acid testing market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Table Global nucleic acid testing market by product 2015-2020 (%)
    • Instruments
    • Reagents
  • Market segmentation by indication
    • Market overview
      • Table Global nucleic acid testing market segmentation
      • Table Global nucleic acid testing market by indication 2015-2020 (%)
    • Infectious diseases
      • Table NAT tests for infectious diseases
      • Table Nucleic acid testing market by indication - infectious diseases 2015-2020 ($ billion)
    • Cancer
      • Table Nucleic acid testing market by indication - cancer 2015-2020 ($ billions)
    • Genetics
      • Table Nucleic acid testing market by indication - genetics 2015-2020 ($ billions)
  • Market segmentation by technology
    • Table Global nucleic acid testing market by technology 2015-2020 (%)
    • Polymerase chain reaction (PCR)
      • Table Market strategy analysis of PCR technology
      • Table Market dynamics of PCR technology
    • Strand displacement amplification (SDA)
      • Table Market strategy analysis of SDA technology
      • Table Market dynamics of SDA technology
    • Ligase chain reaction (LCR)
      • Table Market strategy analysis of LCR technology
      • Table Market dynamics of LCR technology
    • Others
  • Market segmentation by end-users
    • Table Global nucleic acid testing market by end-users 2015-2020 (%)
    • Hospitals
    • Clinics
    • Research institutes
  • Geographical segmentation
    • Nucleic acid testing market in Americas
      • Table Market overview of nucleic acid testing in Americas
      • Table Nucleic acid testing market in Americas 2015-2020 ($ billions)
    • Nucleic acid testing market in the EMEA
      • Table Market overview of nucleic acid testing in EMEA
      • Table Nucleic acid testing market in EMEA 2015-2020 ($ billions)
    • Nucleic acid testing market in the APAC
      • Table Market overview of nucleic acid testing in APAC
      • Table Nucleic acid testing market in APAC 2015-2020 ($ billions)
  • Market drivers
    • Genome engineering and gene editing on rise
    • Higher adoption rate of molecular point-of-care (POC) testing
    • Improved sensitivity for the detection systems
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost of equipment and reagents
    • Stringent regulatory framework
      • Table Market impact of regulatory policies in different countries
    • Risks associated with molecular diagnosis
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Next generation sequencing
      • Table Common methods in next generation sequencing
      • Table Key application areas of next generation sequencing technology
    • Higher adoption rate for NAT
      • Table Comparison between NAT and serological blood screening
    • Advances in precision and personalized medicine
      • Table Features and benefits of personalized medicines - Market impact
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global nucleic acid testing market 2015
      • Table Market penetration of global nucleic acid testing manufacturers (2015)
      • Table Strategic success factors of companies in global nucleic acid testing market
  • Key vendor analysis
    • Abbott Laboratories
      • Table Abbott Laboratories strength assessment
      • Table Abbott Laboratories strategy assessment
      • Table Abbott Laboratories opportunity assessment
    • Roche Molecular Systems
      • Table Roche Molecular Systems strength assessment
      • Table Roche Molecular Systems strategy assessment
      • Table Roche Molecular Systems: Opportunity assessment
    • Siemens Healthineers
      • Table Siemens Healthineers strength assessment
      • Table Siemens Healthineers strategy assessment
      • Table Siemens Healthineers: Opportunity assessment
    • Hologic
      • Table Hologic strength assessment
      • Table Hologic strategy assessment
      • Table Hologic: Opportunity assessment
    • Qiagen
      • Table Qiagen strength assessment
      • Table Qiagen strategy assessment
      • Table Qiagen: Opportunity assessment
    • Key Companies to watch
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report